169 related articles for article (PubMed ID: 13680264)
1. Serum follicle-stimulating hormone level is a predictor of bone mineral density in patients with hormone replacement therapy.
Kawai H; Furuhashi M; Suganuma N
Arch Gynecol Obstet; 2004 Mar; 269(3):192-5. PubMed ID: 13680264
[TBL] [Abstract][Full Text] [Related]
2. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
Stanosz S; Zochowska E; Safranow K; Sieja K; Stanosz M
Metabolism; 2009 Jan; 58(1):1-7. PubMed ID: 19059524
[TBL] [Abstract][Full Text] [Related]
3. Serum estradiol concentration as measured by HPLC-RIA and bone mineral density in postmenopausal women during hormone replacement therapy.
Yasui T; Uemura H; Umino Y; Takikawa M; Kuwahara A; Saito S; Matsuzaki T; Maegawa M; Furumoto H; Miura M; Irahara M
Horm Res; 2004; 61(3):117-25. PubMed ID: 14676459
[TBL] [Abstract][Full Text] [Related]
4. [Evaluation of the hematochemical parameters and bone mineral density of women in physiological menopause treated with hormone replacement therapy with nomegestrol acetate and surgical menopause treated with estrogen replacement. Part II].
Savoca S; D'Agosta S; Lombardo G
Minerva Ginecol; 2007 Jun; 59(3):215-22. PubMed ID: 17576400
[TBL] [Abstract][Full Text] [Related]
5. Identification of early postmenopausal women with no bone response to HRT: results of a five-year clinical trial.
Komulainen M; Kröger H; Tuppurainen MT; Heikkinen AM; Honkanen R; Saarikoski S
Osteoporos Int; 2000; 11(3):211-8. PubMed ID: 10824236
[TBL] [Abstract][Full Text] [Related]
6. Estrogen replacement therapy in postmenopausal women: a study of the efficacy of estriol and changes in plasma gonadotropin levels.
Ushiroyama T; Sakai M; Higashiyama T; Ikeda A; Ueki M
Gynecol Endocrinol; 2001 Feb; 15(1):74-80. PubMed ID: 11293929
[TBL] [Abstract][Full Text] [Related]
7. Sr and Fe relationship with hormone replacement therapy and bone mineral density.
Unfer TC; Müller EI; de Moraes Flores EM; Dressler VL; da Silva JC; Duarte MM; Emanuelli T
Clin Chim Acta; 2007 Sep; 384(1-2):113-7. PubMed ID: 17618614
[TBL] [Abstract][Full Text] [Related]
8. Serum estradiol and gonadotropins level in postmenopausal women with or without hormone replacement.
Limpaphayom K; Taechakraichana N; Kittinunvorakoon C
J Med Assoc Thai; 1997 Mar; 80(3):147-52. PubMed ID: 9175381
[TBL] [Abstract][Full Text] [Related]
9. Bone mineral density and sex hormone status in intellectually disabled women on progestin-induced amenorrhea.
Arvio M; Kilpinen-Loisa P; Tiitinen A; Huovinen K; Mäkitie O
Acta Obstet Gynecol Scand; 2009; 88(4):428-33. PubMed ID: 19330573
[TBL] [Abstract][Full Text] [Related]
10. Prevention of postmenopausal bone loss with long-cycle hormone replacement therapy.
Popp AW; Bodmer C; Senn C; Fuchs G; Kraenzlin ME; Wyss H; Birkhaeuser MH; Lippuner K
Maturitas; 2006 Jan; 53(2):191-200. PubMed ID: 16368472
[TBL] [Abstract][Full Text] [Related]
11. Ultra low-dose hormone replacement therapy and bone protection in postmenopausal women.
Gambacciani M; Cappagli B; Ciaponi M; Pepe A; Vacca F; Genazzani AR
Maturitas; 2008 Jan; 59(1):2-6. PubMed ID: 18063490
[TBL] [Abstract][Full Text] [Related]
12. The relationship between serum dehydroepiandrosterone sulfate concentration and bone mineral density, lipids, and hormone replacement therapy in premenopausal and postmenopausal women.
Osmanagaoglu MA; Okumuş B; Osmanagaoglu T; Bozkaya H
J Womens Health (Larchmt); 2004 Nov; 13(9):993-9. PubMed ID: 15665656
[TBL] [Abstract][Full Text] [Related]
13. The clinical significance of bone mineral density and testosterone levels in Korean men with non-mosaic Klinefelter's syndrome.
Seo JT; Lee JS; Oh TH; Joo KJ
BJU Int; 2007 Jan; 99(1):141-6. PubMed ID: 17092285
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of raloxifene on bone mineral density and serum lipid levels in post-menopausal women with low BMD after discontinuation of hormone replacement therapy.
Song EK; Yeom JH; Shin HT; Kim SH; Shin WG; Oh JM
J Clin Pharm Ther; 2006 Oct; 31(5):421-7. PubMed ID: 16958819
[TBL] [Abstract][Full Text] [Related]
15. Adequate reduction degree of pituitary gonadotropin levels in the clinical management of short-term hormone replacement therapy of women with menopausal symptoms.
Ushiroyama T; Sakuma K; Ikeda A; Ueki M
J Med; 2004; 35(1-6):281-94. PubMed ID: 18084886
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the effects of raloxifene and low-dose hormone replacement therapy on bone mineral density and bone turnover in the treatment of postmenopausal osteoporosis.
Dane C; Dane B; Cetin A; Erginbas M
Gynecol Endocrinol; 2007 Jul; 23(7):398-403. PubMed ID: 17701771
[TBL] [Abstract][Full Text] [Related]
17. Levonorgestrel and 17beta-estradiol given transdermally for the prevention of postmenopausal osteoporosis.
Warming L; Ravn P; Christiansen C
Maturitas; 2005 Feb; 50(2):78-85. PubMed ID: 15653003
[TBL] [Abstract][Full Text] [Related]
18. Factors influencing changes in bone mineral density in patients with anorexia nervosa-related osteoporosis: the effect of hormone replacement therapy.
Legroux-Gerot I; Vignau J; Collier F; Cortet B
Calcif Tissue Int; 2008 Nov; 83(5):315-23. PubMed ID: 18836675
[TBL] [Abstract][Full Text] [Related]
19. Serum follicle-stimulating hormone and luteinizing hormone levels in women aged 35-60 in the U.S. population: the Third National Health and Nutrition Examination Survey (NHANES III, 1988-1994).
Backer LC; Rubin CS; Marcus M; Kieszak SM; Schober SE
Menopause; 1999; 6(1):29-35. PubMed ID: 10100177
[TBL] [Abstract][Full Text] [Related]
20. Thoughts on individualizing hormone replacement therapy based on the postmenopausal health disparities study data.
Gavaler JS
J Womens Health (Larchmt); 2003 Oct; 12(8):757-68. PubMed ID: 14588126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
